The Fort Worth Press - US researchers seek to legitimize AI mental health care

USD -
AED 3.6725
AFN 66.50327
ALL 80.653395
AMD 365.190533
AOA 917.000309
ARS 1493.416007
AUD 1.416772
AWG 1.80125
AZN 1.689851
BAM 1.692154
BBD 2.008721
BDT 123.455081
BHD 0.3761
BIF 2985.970817
BMD 1
BND 1.277984
BOB 11.853211
BRL 5.083898
BSD 0.997309
BTN 94.901089
BWP 13.461555
BYN 2.969692
BYR 19600
BZD 2.005779
CAD 1.39606
CDF 2262.502134
CHF 0.809098
CLF 0.023198
CLP 913.000141
CNY 6.747598
CNH 6.74699
COP 3157.69
CRC 453.361712
CUC 1
CUP 26.5
CVE 95.398565
CZK 21.010974
DJF 177.598394
DKK 6.472445
DOP 58.218911
DZD 132.350167
EGP 49.803294
ERN 15
ETB 160.971007
EUR 0.865819
FJD 2.20855
FKP 0.74148
GBP 0.741655
GEL 2.610398
GGP 0.74148
GHS 11.701051
GIP 0.74148
GMD 73.50146
GNF 8759.111457
GTQ 7.609218
GYD 208.606894
HKD 7.84524
HNL 26.731037
HRK 6.522098
HTG 130.40262
HUF 314.6285
IDR 17816.05
ILS 2.999849
IMP 0.74148
INR 95.19805
IQD 1306.448752
IRR 1375550.000174
ISK 123.469937
JEP 0.74148
JMD 158.382433
JOD 0.708972
JPY 158.207962
KES 128.880029
KGS 87.450078
KHR 4050.85633
KMF 426.000291
KRW 1415.545005
KWD 0.30866
KYD 0.831109
KZT 467.406398
LAK 22517.541811
LBP 89309.055987
LKR 334.518649
LRD 180.013843
LSL 16.202317
LTL 2.95274
LVL 0.60489
LYD 6.343603
MAD 9.294994
MDL 17.342816
MGA 4255.889809
MKD 53.231298
MMK 2099.549369
MNT 3595.852714
MOP 8.059058
MRU 40.09223
MUR 47.250125
MVR 15.449987
MWK 1729.34998
MXN 17.152604
MYR 4.088496
MZN 63.904983
NAD 16.202107
NGN 1361.610134
NIO 36.701693
NOK 9.51214
NPR 151.845026
NZD 1.700955
OMR 0.382805
PAB 0.997314
PEN 3.377444
PGK 4.407375
PHP 60.777936
PKR 276.877947
PLN 3.722597
PYG 5930.040405
QAR 3.64559
RON 4.544397
RSD 101.521437
RUB 81.682483
RWF 1466.50401
SAR 3.744756
SBD 8.065696
SCR 14.45314
SDG 600.504736
SEK 9.49805
SGD 1.279715
SLE 24.598376
SOS 569.989877
SRD 37.8665
STD 20697.981008
STN 21.197622
SVC 8.726386
SZL 16.199029
THB 33.032022
TJS 9.200175
TMT 3.51
TND 2.92983
TRY 47.714801
TTD 6.759762
TWD 32.218603
TZS 2643.56301
UAH 44.66703
UGX 3714.372216
UYU 40.144833
UZS 11927.514351
VES 755.762399
VND 26138.5
VUV 118.557141
WST 2.733716
XAF 567.53013
XAG 0.015799
XAU 0.000232
XCD 2.70255
XCG 1.797449
XDR 0.705825
XOF 567.53013
XPF 103.182603
YER 238.402481
ZAR 16.18135
ZMK 9001.198411
ZMW 18.824028
ZWL 321.999592
  • CMSC

    0.0240

    21.744

    +0.11%

  • BCC

    2.3400

    86.6

    +2.7%

  • JRI

    0.1500

    12.81

    +1.17%

  • CMSD

    -0.1600

    21.82

    -0.73%

  • BCE

    -0.0200

    22.75

    -0.09%

  • GSK

    0.7900

    52.96

    +1.49%

  • BTI

    0.6000

    59.33

    +1.01%

  • RBGPF

    0.7600

    70.5

    +1.08%

  • RIO

    1.4500

    101.1

    +1.43%

  • VOD

    0.1900

    16.19

    +1.17%

  • RYCEF

    0.2300

    20.85

    +1.1%

  • RELX

    0.0485

    35.52

    +0.14%

  • BP

    -0.6000

    41.63

    -1.44%

  • AZN

    1.4100

    161.42

    +0.87%

  • NGG

    0.4700

    80.88

    +0.58%

US researchers seek to legitimize AI mental health care
US researchers seek to legitimize AI mental health care / Photo: © GETTY IMAGES NORTH AMERICA/AFP/File

US researchers seek to legitimize AI mental health care

Researchers at Dartmouth College believe artificial intelligence can deliver reliable psychotherapy, distinguishing their work from the unproven and sometimes dubious mental health apps flooding today's market.

Text size:

Their application, Therabot, addresses the critical shortage of mental health professionals.

According to Nick Jacobson, an assistant professor of data science and psychiatry at Dartmouth, even multiplying the current number of therapists tenfold would leave too few to meet demand.

"We need something different to meet this large need," Jacobson told AFP.

The Dartmouth team recently published a clinical study demonstrating Therabot's effectiveness in helping people with anxiety, depression and eating disorders.

A new trial is planned to compare Therabot's results with conventional therapies.

The medical establishment appears receptive to such innovation.

Vaile Wright, senior director of health care innovation at the American Psychological Association (APA), described "a future where you will have an AI-generated chatbot rooted in science that is co-created by experts and developed for the purpose of addressing mental health."

Wright noted these applications "have a lot of promise, particularly if they are done responsibly and ethically," though she expressed concerns about potential harm to younger users.

Jacobson's team has so far dedicated close to six years to developing Therabot, with safety and effectiveness as primary goals.

Michael Heinz, psychiatrist and project co-leader, believes rushing for profit would compromise safety.

The Dartmouth team is prioritizing understanding how their digital therapist works and establishing trust.

They are also contemplating the creation of a nonprofit entity linked to Therabot to make digital therapy accessible to those who cannot afford conventional in-person help.

- Care or cash? -

With the cautious approach of its developers, Therabot could potentially be a standout in a marketplace of untested apps that claim to address loneliness, sadness and other issues.

According to Wright, many apps appear designed more to capture attention and generate revenue than improve mental health.

Such models keep people engaged by telling them what they want to hear, but young users often lack the savvy to realize they are being manipulated.

Darlene King, chair of the American Psychiatric Association's committee on mental health technology, acknowledged AI's potential for addressing mental health challenges but emphasizes the need for more information before determining true benefits and risks.

"There are still a lot of questions," King noted.

To minimize unexpected outcomes, the Therabot team went beyond mining therapy transcripts and training videos to fuel its AI app by manually creating simulated patient-caregiver conversations.

While the US Food and Drug Administration theoretically is responsible for regulating online mental health treatment, it does not certify medical devices or AI apps.

Instead, "the FDA may authorize their marketing after reviewing the appropriate pre-market submission," according to an agency spokesperson.

The FDA acknowledged that "digital mental health therapies have the potential to improve patient access to behavioral therapies."

- Therapist always in -

Herbert Bay, CEO of Earkick, defends his startup's AI therapist Panda as "super safe."

Bay says Earkick is conducting a clinical study of its digital therapist, which detects emotional crisis signs or suicidal ideation and sends help alerts.

"What happened with Character.AI couldn't happen with us," said Bay, referring to a Florida case in which a mother claims a chatbot relationship contributed to her 14-year-old son's death by suicide.

AI, for now, is suited more for day-to-day mental health support than life-shaking breakdowns, according to Bay.

"Calling your therapist at two in the morning is just not possible," but a therapy chatbot remains always available, Bay noted.

One user named Darren, who declined to provide his last name, found ChatGPT helpful in managing his traumatic stress disorder, despite the OpenAI assistant not being designed specifically for mental health.

"I feel like it's working for me," he said.

"I would recommend it to people who suffer from anxiety and are in distress."

F.Carrillo--TFWP